| Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy (NCT04409314) | University of California, San Francisco | 2020-04-16 |
| Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America (NCT04089488) | AIDS Malignancy Consortium | 2020-01-17 |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care (NCT03743649) | M.D. Anderson Cancer Center | 2019-07-17 |
| Financial Distress in Advanced Cancer Patients (NCT04053517) | M.D. Anderson Cancer Center | 2019-07-02 |
| Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits (NCT03856060) | M.D. Anderson Cancer Center | 2019-03-30 |
| Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings (NCT04186884) | M.D. Anderson Cancer Center | 2019-03-26 |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085) | M.D. Anderson Cancer Center | 2018-11-14 |
| A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy (NCT03525873) | M.D. Anderson Cancer Center | 2018-08-02 |
| Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer (NCT03021486) | M.D. Anderson Cancer Center | 2017-06-05 |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer (NCT02595866) | National Cancer Institute (NCI) | 2016-04-04 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (NCT02491632) | M.D. Anderson Cancer Center | 2015-08-13 |
| PCRC-Supported Legacy Intervention in Pediatric Palliative Care (NCT04059393) | Vanderbilt-Ingram Cancer Center | 2015-07-27 |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes (NCT02286687) | M.D. Anderson Cancer Center | 2014-12-22 |
| Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II) (NCT02152254) | M.D. Anderson Cancer Center | 2014-05-13 |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (NCT01790152) | Children's Oncology Group | 2014-03-05 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434) | M.D. Anderson Cancer Center | 2012-10-16 |
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers (NCT01624766) | M.D. Anderson Cancer Center | 2012-06-19 |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer (NCT01582191) | M.D. Anderson Cancer Center | 2012-05-14 |